The largest database of trusted experimental protocols

Begm bronchial epithelial cell growth medium bulletkit

Manufactured by Lonza
Sourced in United States, Switzerland

BEGM Bronchial Epithelial Cell Growth Medium BulletKit is a cell culture medium designed for the growth and maintenance of human bronchial epithelial cells. The kit includes all the essential components required for culturing these cells.

Automatically generated - may contain errors

15 protocols using begm bronchial epithelial cell growth medium bulletkit

1

In Vitro Cell Culture Optimization

Check if the same lab product or an alternative is used in the 5 most similar protocols
WI-38 were purchased from Sigma-Aldrich (St. Louis, MO, USA) and grown in EMEM medium with 10% fetal bovine serum, 2 mM of L-glutamine, 1% of non-essential amino acids, and standard Penicillin Streptomycin solution (Sigma-Aldrich, St. Louis, MO, USA). The epithelial cell line NHBE was purchased from Lonza (Lonza Walkersville Inc., Walkersville, MD, USA) and cultured in BEGM Bronchial Epithelial Cell Growth Medium BulletKit (Lonza Walkersville Inc., Walkersville, MD, USA). Human Gingival Fibroblasts were obtained from the American Type Culture Collection (ATCC, Manassas, VA, USA); the cells were grown in Dulbecco’s Modified Eagle Medium (DMEM) supplemented with 10% fetal bovine serum, 100 U/mL, penicillin, and 0.1 mg/mL streptomycin. All the experiments (n = 6) were performed after reaching 80–90% confluence (passage three to ten). The viability of the cells was evaluated by Presto Blue (BD Pharmingen, Franklin Lakes, NJ, USA), and the absorbance was measured at 570 nm.
+ Open protocol
+ Expand
2

Cell Culture Protocols for Autophagy Research

Check if the same lab product or an alternative is used in the 5 most similar protocols
HEK 293T, Huh7 and HeLa cells were obtained from ATCC and maintained in ATCC recommended media. 293T APEX2-nsp6 cells were grown in DMEM supplemented with 10% fetal bovine serum and antibiotic. STX17KO HeLa, FIP200KO HeLa, RUBCNKO HeLa, HexaKO HeLa, TBK1KO HeLa and STX17KO Huh7, ATG9KO Huh7 cells were cultured in DMEM supplemented with 10% fetal bovine serum and antibiotic as described previously (Gu et al., 2019 (link); Kumar et al., 2019 ). E-SYT2KO and parental wild type HeLa cells were cultured as described previously (Saheki et al., 2016 (link)). HEK293A SIGMAR1KO and parental wild type HEK293A cells were grown as described previously (Yang et al., 2019 (link)). Primary NHBE (normal human bronchial epithelial) cells were obtained from Lonza and cultured in media from Lonza (BEGM bronchial epithelial cell growth medium BulletKit; Catalog #: CC-3170).
+ Open protocol
+ Expand
3

Bacterial and Cell Line Cultivation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Every strain used in the study was purchased from the Korean Culture Center of Microorganisms (KCCM, Seoul, Korea) or the American Type Culture Collection (ATCC, Manassas, VA, USA). The following bacterial strains were used in this study: Escherichia coli KCCM 11234 (E. coli), Pseudomonas aeruginosa ATCC 9027 (P. aeruginosa), Bacillus cereus KCCM 21366 (B. cereus), Staphylococcus aureus KCCM 11335 (S. aureus), and methicillin-resistant S. aureus ATCC 33591 (MRSA). Bacterial strains were maintained in tryptic soy broth (TSB, Difco Laboratories, Detroit, MI, USA) and cultured under shaking incubation at 37°C. In addition, the following human cell lines were used in this study: THP-1 monocytes (ATCC TIB-202), primary adipose-derived mesenchymal stem cell (hADMSC; CEFO Co., Seoul, Korea), normal bronchial epithelial cells BEAS-2B (ATCC CRL-9609), and lung carcinoma cells H460 (ATCC HTB-177). THP-1 and H460 cells were cultured in RPMI 1640 medium (Welgene Inc., Gyeongsan, Gyeongsangbuk-do, Korea) supplemented with 10% fetal bovine serum (Gibco), 1% penicillin and streptomycin (Gibco), and sodium pyruvate (Welgene Inc.). hADMSC and BEAS-2B cells were cultured in CEFOgro™ Human MSC Growth Medium (CEFO Co.) and BEGM™ Bronchial Epithelial Cell Growth Medium BulletKit™ (Lonza, Basel, Switzerland), respectively. The cells were maintained under humidified air with 5% CO2 at 37°C.
+ Open protocol
+ Expand
4

In Vitro Respiratory Cell Culture

Check if the same lab product or an alternative is used in the 5 most similar protocols
Experiments in this study were conducted using BEAS-2B cells (RRID: CVCL_0168), A549 cells (RRID: CVCL_0023), and HNEpC. These are respiratory epithelial cell types widely used as in vitro cell culture models. BEAS-2B and A549 cell lines were purchased from Duke Cell Culture Facility (Source: ATCC, Manassas, VA) and HNEpC from PromoCell GmbH (Heidelberg, Germany). BEAS-2B cells were cultured in BEGM Bronchial Epithelial Cell Growth Medium BulletKit (Lonza, Walkersville, IL) containing BEGM basal medium and SingleQuots supplements and growth factors. Cells were plated onto flasks and plates coated with a mixture of fibronectin (0.01 mg/mL; Sigma-Aldrich, Saint Louis, MO), bovine collagen type I (0.03 mg/mL; Sigma-Aldrich) and bovine serum albumin (0.01 mg/mL; Sigma-Aldrich) dissolved in cell culture medium and overnight incubated at 37°C in a 5% CO2 and 95% humid atmosphere. A549 cells were cultured in F-12K medium supplemented with 10% fetal bovine serum and 100 units/mL penicillin and 0.1 mg/mL streptomycin. HNEpC were cultured in Airway Epithelial Cell Growth Medium (PromoCell) that contained growth supplements, growth factors and antibiotic–antimycotic mix (10 000 units/mL of penicillin, 10 000 µg/mL of streptomycin, and 25 µg/mL of Amphotericin B; ThermoFisher Scientific, Waltham, MA).
+ Open protocol
+ Expand
5

PCSK9 Expression in Airway Epithelial Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
The BEAS-2B cells were purchased from ATCC and cultured at 37°C in BEGM Bronchial epithelial cell growth medium bullet kit (CC-3170, Lonza) following manufacturer's instruments. The cells were incubated with or without SB431542 (S4317, Sigma Aldrich) in response to TGFβ1 (240-B, R&D systems). The concentrated supernatant and cell lysates of BEAS-2B were subjected to SDS-PAGE and transferred to nitrocellulose membrane. Immunoblot was performed with antibody against PCSK9 and the bands were visualized by chemiluminescence (Amersham Imager 600).
+ Open protocol
+ Expand
6

Cell Line Maintenance and Stimulation Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cell lines were obtained from ECACC (SK-GT 4, OE33, FLO-1); ATCC (GO (CP-B)); and Invivogen (THP1-XBlueTM-CD14 (NF-kB/AP-1- Reporter Monocytes)). Cell lines were maintained in culture for no more than 20 passages. Cells were not authenticated in the past year. Cell lines from ECACC were tested for mycoplasma contamination twice per year using PCR as described by Young et al. [19 (link)]. SK-GT 4, OE33, FLO-1 and THP1-XBlue-CD14 were cultured in RPMI 1640 GlutaMAX (Thermo Fisher Scientific, Waltham, MA, USA, Catalog no. 61870036) with 10% foetal bovine serum (Labtech, Sorisole, Italy, Catalog no. FCS-SA/500) and penicillin–streptomycin (100 U/mL, 100 µg/mL, Catalog No. 15140148). GO were cultured in BEGM™ Bronchial Epithelial Cell Growth Medium Bullet kit (Lonza, Basel, Switzerland, Catalog no. CC-3170). Where indicated, cells were pre-incubated (1 h) with the TLR2 neutralising antibody (αTLR2 (0.4–40 μg/mL), T2.5, Invivogen) prior to stimulation. Cells were stimulated using Pam3CSK4 (P3C; 0.05 μg/mL, Invivogen, San Diego, CA, USA, tlrl-pms), Pam2CSK4 (P2C; 0.05 μg/mL, Invivogen, tlrl-pm2s-1), recombinant HMGB1 expressed from HEK 293 (stock conc. 50 µg/mL; Sigma-Aldrich, St. Louis, MO, USA; SRP6265), and LPS from Escherichia coli 0111:B4 (1 μg/mL, Sigma-Aldrich, L2630), or with 50% conditioned media (CM), generated as described below.
+ Open protocol
+ Expand
7

Primary Bronchial Epithelial Cell Culture

Check if the same lab product or an alternative is used in the 5 most similar protocols
Primary normal human bronchial epithelial (NHBE) and DHBE cells were purchased from Lonza (Basel, Switzerland). Cell cultures were performed according to the manufacturer’s protocol. Cells were grown in bronchial epithelial cell basal media (BEGM™ Bronchial Epithelial Cell Growth Medium BulletKit™; Lonza), supplemented with 2 mL bovine pituitary extract, 0.5 mL hydrocortisone, 0.5 mL human epidermal growth factor (hEGF), 0.5 mL epinephrine, 0.5 mL transferrin, 0.5 mL insulin, 0.5 mL retinoic acid, 0.5 mL triiodothyronine, and 0.5 mL GA1000. Cells were maintained at 37°C in a 5% CO2 incubator and passaged with Reagent-Pack (Lonza) containing trypsin–EDTA (EDTA, trypsin neutralizing solution, and HEPES [4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid]-buffered solution). Cells were harvested for NGS analysis after cultivation from primary cells for one generation.
+ Open protocol
+ Expand
8

Clonal BEAS-2B Epithelial Cell Line

Check if the same lab product or an alternative is used in the 5 most similar protocols
The human bronchial epithelial cell line BEAS-2B
(CRL-9609) was purchased from ATCC (Manassas, VA). Cells were tested
regularly for mycoplasma contamination. BEAS-2B were cultured using
a BEGM Bronchial Epithelial Cell Growth Medium BulletKit (Lonza, Basel,
Switzerland) at 37 °C in a humidified atmosphere with 5% CO2. In order to obtain a clonal parental BEAS-2B cell line,
cells were seeded at limited dilution (500 cells per 96-well plate).
Cells were left to recover until they were sufficiently viable to
transfer (4–8 days), after which wells were visually inspected
to identify those containing a single cell. These clones were expanded
and passaged to Primaria (Corning, Corning, NY) 6-well plates and
then to Primaria 10 cm dishes. The clonal parental population was
chosen on the criteria that the cells displayed the same morphology
as BEAS-2B cells and had the same division time. DNA was extracted
(see Section 2.6),
and clonality of the population was confirmed by whole-genome sequencing.
The resulting clonal parental BEAS-2B cell line was cultured in the
same way as the regular BEAS-2B cell line.
+ Open protocol
+ Expand
9

Cell Culture Protocol for Fibroblasts and Epithelium

Check if the same lab product or an alternative is used in the 5 most similar protocols
WI-38 and HFL1—fibroblast cell lines—were purchased from Sigma-Aldrich (St. Louis, MO, USA). The cells were grown in EMEM medium (WI-38) and HAM’s12 medium (HFL1) with an addition of 10% fetal bovine serum, 2 mM of L-glutamine, 1% of non-essential amino acids, and standard Penicillin Streptomycin solution (Sigma-Aldrich, St. Louis, MO, USA). The epithelial cell line—NHBE—was purchased from Lonza (Lonza Walkersville Inc. Walkersville, MD, USA) and cultured in BEGM Bronchial Epithelial Cell Growth Medium BulletKit (Lonza Walkersville Inc. Walkersville, MD, USA). The experiments (n = 6) were performed after reaching 80–90% confluence (passage three to eight) by the cells. The viability of the cells was assessed using Presto Blue (BD Pharmingen, Franklin Lakes, NJ, USA) and measuring the absorbance at 570 nm.
+ Open protocol
+ Expand
10

Fibroblast and Epithelial Cell Culture Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Fibroblast cell lines—WI‐38 and HFL1—were purchased from Sigma‐Aldrich (St. Louis, MO USA) and grown in EMEM medium (WI‐38) and HAM's12 medium (HFL1) with 10% foetal bovine serum, 2 mM of L‐glutamine, 1% of non‐essential amino acids and standard Penicillin‐Streptomycin solution (Sigma‐Aldrich, St. Louis, MO). The epithelial cell line—NHBE—was purchased from Lonza (Lonza Walkersville Inc. MD, USA) and cultured in BEGM Bronchial Epithelial Cell Growth Medium BulletKit (Lonza Walkersville Inc. Walkersville, MD, USA). All the experiments (n = 6) were performed after reaching 80–90% confluence (passage three to nine) by the cells. The viability of the cells was assessed by adding 10 µl of Presto Blue (BD Pharmingen, Franklin Lakes, NJ, USA), and the absorbance was measured at 570 nm.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!